Without a baseline, you cannot confirm whether subsequent changes are due to the therapy or pre-existing trends
Medical Writing/Editorial Assistance Medical writing support was provided by Caroline Freeman PhD of Oxford PharmaGenesis, Oxford, UK with funding from Novo Nordisk A/S, Sborg, Denmark, in accordance with Good Publication Practice (GPP 2022) guidelines (www.ismpp.org/gpp-2022)
For example, Primarily, it is used to treat various liver conditions, such as fatty liver or other diseases
World Psychiatry 17 , 316329 (2018)
44,45 Using the FDA Sentinel System, Maro et al found that the incidence of NAION was not increased within 6 months of semaglutide initiation
Willard, Jonathan D